Glyceryl Trinitrate Martindale Pharma (Glyceryl Trinitrate)

Glyceryl trinitrate is prescribed for several cardiovascular conditions where rapid relief of chest pain is required.

• Acute angina pectoris: immediate relief of chest pain during an angina attack.
• Prophylaxis of angina: prevention of recurrent angina episodes in patients with stable coronary disease.
• Management of heart failure associated with acute coronary syndrome, particularly when rapid hemodynamic support is needed.
• Adjunct therapy during diagnostic procedures such as cardiac stress testing to control ischemic symptoms.
• Emergency treatment of myocardial ischemia when other vasodilators are contraindicated.

The sublingual formulation of glyceryl trinitrate may produce a range of adverse effects, most of which are related to its vasodilatory action. These effects are dose‑dependent and usually resolve as the drug wears off.

Common

• Headache, often throbbing, resulting from cerebral vasodilation.
• Facial flushing or a sensation of warmth spreading across the neck and upper chest.
• Dizziness or light‑headedness, particularly when moving from a seated to a standing position.
• Mild to moderate hypotension manifested by a temporary reduction in systolic blood pressure.

Serious

• Severe hypotension that can lead to fainting (syncope) and requires immediate medical attention.
• Reflex tachycardia, an accelerated heart rate that may worsen underlying myocardial ischemia.

When prescribing glyceryl trinitrate, clinicians consider several precautions to minimise risks and ensure safe use.

• Assess blood pressure before each dose; avoid use in patients with baseline hypotension.
• Use with caution in individuals with severe aortic stenosis or hypertrophic cardiomyopathy.
• Monitor for signs of tolerance with chronic therapy; dose‑free intervals may be required.
• Avoid abrupt discontinuation in patients receiving long‑term nitrate therapy to prevent rebound angina.
• Counsel patients to remain seated during administration to reduce the chance of dizziness or syncope.
• Pregnancy and lactation status should be evaluated, as safety data are limited.

Glyceryl trinitrate can interact with other medicines, altering its effectiveness or increasing adverse effects; awareness of key interactions helps guide therapy.

Avoid

• Phosphodiesterase‑5 inhibitors (e.g., sildenafil, tadalafil) because combined vasodilation may cause profound hypotension.
• Other nitrate preparations or nitroglycerin patches, which can lead to additive blood‑pressure lowering.
• Guanylate cyclase stimulators, which may amplify nitric‑oxide mediated effects.

Use with caution

• Antihypertensive agents such as beta‑blockers, calcium‑channel blockers, or ACE inhibitors, which may enhance hypotensive response.
• Diuretics, especially loop diuretics, that can predispose to volume depletion and low blood pressure.
• Alcohol, which can increase the risk of dizziness and hypotension.